癌症（英文版）2015，Vol.34Issue(12)：573-582,10.DOI:10.1186/s40880-015-0065-z
SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients
SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients
Yi-Wei Wang 1Shao-Dan Zhang 2Wen-Ji Xue 3Mei-Ling Zhu 1Lei-Zhen Zheng1
作者信息
- 1. Department of Oncology,Xin Hua Hospital Affiliated To Shanghai Jiaotong University School of Medicine,NO.1665,Kong Jiang Road,Shanghai 200092,P.R.China
- 2. Department of Experimental Research,State Key Laboratory of Oncology in South China
- 3. Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou 510060,Guangdong,P.R. China
- 折叠
摘要
关键词
Serine hydroxymethyltransferase 1 (SHMT1)/Polymorphism/Non-Hodgkin lymphoma/Meta-analysisKey words
Serine hydroxymethyltransferase 1 (SHMT1)/Polymorphism/Non-Hodgkin lymphoma/Meta-analysis引用本文复制引用
Yi-Wei Wang,Shao-Dan Zhang,Wen-Ji Xue,Mei-Ling Zhu,Lei-Zhen Zheng..SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients[J].癌症（英文版）,2015,34(12):573-582,10.
